Idenix hepatitis B therapy authorized in China
Hepatitis B remains a significant global health care concern, particularly in China where it affects more than 100 million people. Sebivo, generic name telbivudine, is expected to be
The US Food and Drug Administration (FDA) has granted accelerated approval to Bristol Myers Squibb’s (BMS) Zenbexus (iberdomide), along with daratumumab and hyaluronidase-fihj and dexamethasone (ZDd), to treat adult multiple myeloma (MM) patients.